dichlororibofuranosylbenzimidazole has been researched along with Glioma in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, A | 1 |
| Lakka, SS | 1 |
| Mohanam, S | 1 |
| Boyd, D | 1 |
| Rao, JS | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Glioma
| Article | Year |
|---|---|
Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines.
Topics: beta-Galactosidase; Chloramphenicol O-Acetyltransferase; Dichlororibofuranosylbenzimidazole; Electro | 2001 |